Next Generation News and Research

RSS

HRR mutational status associated with survival outcomes in recurrent platinum-sensitive ovarian cancer

Results of a biomarker analysis of the NRG Oncology NRG-GY004 trial were presented at a Seminal Session during the Society for Gynecologic Oncology's (SGO) Annual Meeting on Women's Cancer in March 2022.

19 Mar 2022

Impact of new COVID vaccinations as novel variants emerge

Researchers explores the changing value of COVID-19 vaccines in a scenario of dynamic immunity and rapidly evolving variants of concern.

17 Mar 2022

Doctors and nurses highlight what is needed to fill gaps and future-proof the healthcare system

Thousands of doctors and nurses from across the globe reveal what is needed to fill gaps and future-proof today’s healthcare system in a new report from Elsevier Health, published two years after the COVID-19 pandemic began.

16 Mar 2022

‘Foreign body reaction’ to implants can be reduced by incorporating drug into silicone coating

Long-term use of implantable electronic medical devices – such as pacemakers and cochlear implants – is hampered by the body's reaction to foreign bodies.

14 Mar 2022

New smartphone app can calculate users’ genetic risk for coronary artery disease

A Scripps Research team developed a smartphone app that can calculate users' genetic risk for coronary artery disease (CAD) - and found that users at high risk sought out appropriate medication after using the app.

14 Mar 2022

Prenatal mindfulness intervention may improve health outcomes in offspring, study shows

Infants whose mothers participated in a mindfulness-based program during pregnancy had healthier stress responses at 6 months old, a new UC San Francisco study found.

10 Mar 2022

Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants

Researchers explored strategies to develop an mRNA-based COVID-19 vaccine that could elicit safer and wider protection against SARS-CoV-2 variants of concern.

10 Mar 2022

Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

New research describes a novel approach whereby SARS-2 antigens were analyzed for conserved sites that may be targeted by broadly neutralizing antibodies that will confer immunity to other Sarbecoviruses.

10 Mar 2022

New analysis method to identify interacting proteins in a protein degrader-dependent manner

Protein degraders, which induce the protein degradation of target proteins, are expected to be the "next-generation drugs" because they can remove disease-related proteins from cells.

8 Mar 2022

Study explores immune escape mutations caused by prolonged viral shedding in immunocompromised COVID-19 patient

A new study examined a unique case of extended viral shedding in an immunocompromised patient that produced a series of SARS-CoV-2 immune escape mutations over a seven-month period.

8 Mar 2022

Thermostable next-generation vaccine candidate against SARS-CoV-2 variants of concern studied in mice

Researchers developed a highly thermo-tolerant vaccine candidate that elicited high nAb titers in mice against several SARS-CoV-2 variants of concerns.

8 Mar 2022

Current and future perspectives of mRNA technology

New research reports on the current and future perspectives on messenger ribonucleic acid technology, the platform on which the first successful COVID-19 vaccine was based.

8 Mar 2022

International Women's Day 2022: Breaking the Bias

The IWD theme for 2022 is #BreaktheBias; coming together to forge women's equality.

8 Mar 2022

Current progress in SARS-CoV-2 vaccine candidates

In a new study, researchers illustrated the current progress and obstacles in COVID-19 vaccine development.

7 Mar 2022

Canopy Biosciences launches next-generation ChipCytometry™ instrument for spatial biology with sub-cellular resolution

Canopy Biosciences, a Bruker Company, today announced the commercial launch of the CellScape™ system, the next generation in ChipCytometry™ instrumentation, advancing the cutting-edge for quantitative in situ spatial phenotyping.

From Bruker Nano Surfaces and Metrology 7 Mar 2022

Government makes progress towards manifesto commitment of delivering 50,000 more nurses by 2024

The government is on track to meet its manifesto commitment to deliver 50,000 more nurses in the NHS by 2024, with over 27,000 more nurses now working across the NHS.

7 Mar 2022

Combating COVID cytokine storm with targeted nucleic acid therapies

Researchers examine current nucleic acid-based treatments against COVID-19 and their methods of action.

6 Mar 2022

Study may pave the way for better multiple sclerosis drugs

Investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have discovered how a drug for multiple sclerosis interacts with its targets, a finding that may pave the way for better treatments.

4 Mar 2022

COVID-19 and the life sciences; what have we learned and where are we going?

News-Medical attended the 2022 SLAS press briefing where Peter Simpson, Michael Girardi, and Simon Meffan-Main gave their thoughts on the life sciences sector post-COVID-19.

From Society for Laboratory Automation and Screening (SLAS) 4 Mar 2022

Government invests £260 million to support health research and life sciences manufacturing

Patients across the country are set to benefit from cutting-edge medical advances and treatments as the government invests £260 million today (Wednesday 2 March) to support research and development, as well as the manufacturing of new drugs, devices and diagnostics.

2 Mar 2022

Next Generation News and Research

HRR mutational status associated with survival outcomes in recurrent platinum-sensitive ovarian cancer

Impact of new COVID vaccinations as novel variants emerge

Doctors and nurses highlight what is needed to fill gaps and future-proof the healthcare system

‘Foreign body reaction’ to implants can be reduced by incorporating drug into silicone coating

New smartphone app can calculate users’ genetic risk for coronary artery disease

Prenatal mindfulness intervention may improve health outcomes in offspring, study shows

Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants

Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

New analysis method to identify interacting proteins in a protein degrader-dependent manner

Study explores immune escape mutations caused by prolonged viral shedding in immunocompromised COVID-19 patient

Thermostable next-generation vaccine candidate against SARS-CoV-2 variants of concern studied in mice

Current and future perspectives of mRNA technology

International Women's Day 2022: Breaking the Bias

Current progress in SARS-CoV-2 vaccine candidates

Canopy Biosciences launches next-generation ChipCytometry™ instrument for spatial biology with sub-cellular resolution

Government makes progress towards manifesto commitment of delivering 50,000 more nurses by 2024

Combating COVID cytokine storm with targeted nucleic acid therapies

Study may pave the way for better multiple sclerosis drugs

COVID-19 and the life sciences; what have we learned and where are we going?

Government invests £260 million to support health research and life sciences manufacturing

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News